TY  - CHAP
M1  - Book, Section
TI  - COVID-19 & The Kidney
A1  - Dirkx, Tonja C.
A1  - Woodell, Tyler B.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
A2  - McQuaid, Kenneth R.
PY  - 2022
T2  - Current Medical Diagnosis & Treatment 2022
AB  - Key  Clinical  Updates  in  COVID-19  &  The  KidneyNearly  half  of  patients  hospitalized  with  COVID-19  present  with  or  develop  AKI,  which  is  associated  with  poorer  prognosis.The  most  common  cause  of  AKI  in  patients  with  COVID-19  is  acute  tubular  necrosis  related  to  a  high  inflammatory  state  (termed  “cytokine  storm”).Treatment  of  COVID-19–related  AKI  is  largely  supportive.Urinalysis  may  reveal  hematuria,  reflecting  endothelial  injury  and  fibrin  thrombi  that  are  commonly  observed  on  biopsy.Another  emerging  entity  described  is  COVID-19–associated  collapsing  glomerulopathy,  which  is  a  type  of  focal  segmental  glomerulosclerosis.The  role  of  corticosteroids  in  COVID-19–associated  collapsing  glomerulopathy  is  under  investigation.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1184183053
ER  -